Testing effectiveness (Phase 2)Study completedNCT02212535
What this trial is testing
Assessment of Tolerance of Mobilizing Peripheral Hematopoietic Stem Cells by Plerixafor in Sickle Cell Patients
Who this might be right for
Major Sickle Cell Syndrome of Type SS or Sβ Thalassemia
Assistance Publique - Hôpitaux de Paris 3